Free Trial
NASDAQ:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.49 -0.03 (-5.22%)
As of 03:56 PM Eastern

About Biotricity Stock (NASDAQ:BTCY)

Key Stats

Today's Range
$0.47
$0.53
50-Day Range
$0.31
$0.55
52-Week Range
$0.19
$1.30
Volume
30,273 shs
Average Volume
37,044 shs
Market Capitalization
$12.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

The “Miracle Metal” that saved 379 lives
According to Airbus, it’s all thanks to a “miracle metal” built into the aircraft’s frame. This same material is now being rushed into AI chips, defense systems, EV batteries, and even cloud computing infrastructure. It’s 400x stronger than steel & 85% lighter. And now, thanks to a breakthrough at MIT, it can be produced for just 90 cents a gram.
H.C. Wainwright Sticks to Its Hold Rating for Biotricity (BTCY)
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $0.2899 at the start of the year. Since then, BTCY stock has increased by 69.0% and is now trading at $0.49.
View the best growth stocks for 2025 here
.

Biotricity, Inc. (NASDAQ:BTCY) released its quarterly earnings data on Thursday, June, 27th. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.36) by $0.11. The company earned $3.18 million during the quarter, compared to analyst estimates of $3.20 million.

Biotricity (BTCY) raised $15 million in an IPO on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include TransDigm Group (TDG), Taiwan Semiconductor Manufacturing (TSM), Wix.com (WIX), Datadog (DDOG), Quanta Services (PWR), PayPal (PYPL) and Royal Caribbean Cruises (RCL).

Company Calendar

Last Earnings
6/27/2024
Today
5/14/2025
Next Earnings (Estimated)
6/25/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BTCY
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,090,000.00
Pretax Margin
-80.42%

Debt

Sales & Book Value

Annual Sales
$12.06 million
Price / Cash Flow
N/A
Book Value
($1.30) per share
Price / Book
-0.38

Miscellaneous

Free Float
22,075,000
Market Cap
$12.21 million
Optionable
Optionable
Beta
1.22
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:BTCY) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners